Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹5.6 LQualified Make: HAIN LIFESCIENCE
Model: GENOTYPE MTBDR SL V2.0 + GENOLYSE 96 TESTS 43 A OKHLA INDUSTRIAL ESTATE PHASE III NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | Make: HAIN LIFESCIENCE
Model: GENOTYPE MTBDR SL V2.0 + GENOLYSE 96 TESTS | L1 | Qualified |
Tender Value
₹6.2 L
EMD Value
Exempted
Closing Date
27 Nov 2024, 3:00 pmClosed
Line Probe Assay Kit for Second Line Drugs under NTEP (Q1) ( PAC Only )
7129354
GEM/2024/B/5599753
Two Packet Bid
Line Probe Assay Kit for Second Line Drugs under NTEP
GeM Contract
30 days
Uttar Pradesh; Gorakhpur
Total value wise evaluation
PRODUCT
Awarded to BIOMERIEUX INDIA PRIVATE LIMITED
₹5.6 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| HAIN LIFESCIENCE Line Probe Assay Kit for Second Line Drugs | HAIN LIFESCIENCE / GENOTYPE MTBDR SL V2.0 + GENOLYSE 96 TESTS | HSN not specified by seller | 7 pieces | 80,634 | 564,438 |
6 documents required · 6 mandatory
3 yrs
₹3
10%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Line Probe Assay Kit for Second Line Drugs under NTEP (Q1) ( PAC Only ) | Balaveer Ram 273013,MEDICALCOLLEGE | 7 | 30 days |
Exempted
18 Dec 2024
12 Nov 2024
27 Nov 2024
contract_GEMC-511687777908272.pdf
GEM_CONTRACT • 0.06 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7129354.pdf
GEM_BID
1731402509.pdf
OTHER
line_probe_assay_for_second_line_drugs_2024-07-05-17-06-59_a19e4d6203df0ff5cb8fa738d688aaf8.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .